Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 10 IN PLASTIC CONTAINER versus DEXTROSE 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DEXTROSE 10 IN PLASTIC CONTAINER versus DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 10% IN PLASTIC CONTAINER vs DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intravenous dextrose provides a source of calories and water for hydration. Dextrose is metabolized to carbon dioxide and water, yielding energy (approximately 3.4 kcal/g). It also stimulates insulin secretion and promotes glycogen synthesis.
Dextrose is a monosaccharide that provides a source of calories and fluid for parenteral nutrition. It increases blood glucose levels and is metabolized to carbon dioxide and water, providing energy. It also serves as a source of water for hydration.
Intravenous infusion, 500-1000 mL (50-100 g dextrose) as a single dose, rate determined by clinical condition; typical maintenance 100-125 mL/h.
Intravenous infusion: 500-1000 mL as needed based on fluid and caloric requirements. Typical rate: 100-200 mL/hour for maintenance. Maximum infusion rate: 0.5-0.8 g/kg/hour.
None Documented
None Documented
The metabolic half-life of glucose is 1.5–2.5 hours; however, the plasma half-life of infused dextrose is approximately 1.5–2 hours, with clinical context indicating that doses >0.5 g/kg/hour can exceed oxidative capacity, leading to hyperglycemia.
Intravenous: 1.5-2.5 hours for glucose clearance; prolonged in renal impairment or diabetes mellitus
Glucose is primarily metabolized via glycolysis and oxidative phosphorylation to CO2 and water; less than 5% is excreted unchanged in urine under normal conditions. In hyperglycemia with glycosuria, up to 50% may be lost renally.
Renal: negligible as unchanged drug; metabolized to water and carbon dioxide, excreted via lungs (>90%) and urine (glucose normally <0.1%)
Category C
Category C
Intravenous Fluid
Intravenous Fluid